- Home
- PLSE
as 06-20-2025 4:00pm EST
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | HAYWARD |
| Market Cap: | 1.1B | IPO Year: | 2016 |
| Target Price: | N/A | AVG Volume (30 days): | 182.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.70 - $25.00 | Next Earning Date: | 08-11-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Pulse Biosciences Inc (DE) (PLSE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| UECKER DARRIN | PLSE | Chief Technology Officer | Jun 12 '25 | Sell | $16.19 | 30,000 | $485,700.00 | 137,872 |
Latest Pulse Biosciences Inc (DE) News
PLSE Breaking Stock News: Dive into PLSE Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
Insider Purchases Worth US$2.70m See Losses As Pulse Biosciences Market Value Drops To US$1.1b
Business Wire
a month ago
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
a month ago
Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership
GuruFocus.com
a month ago
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
Business Wire
a month ago
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results
Business Wire
2 months ago
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
Business Wire
2 months ago
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
Business Wire
2 months ago
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compare PLSE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PLSE Pulse Biosciences Inc (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.